P

Inventor

RUEGER PETRA

DE23 patents
⚠️ This page may combine multiple inventors who share the name “RUEGER PETRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

20 patents
US7462639B2Dec 9, 2008

Aminopyrazole derivatives

HOFFMANN LA ROCHE46 citations91
US6627439B2Sep 30, 2003

Antibodies against SEMP1(p23)

HOFFMANN LA ROCHE26 citations90
US11603411B2Mar 14, 2023

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE9 citations85
US10941205B2Mar 9, 2021

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE10 citations85
US10011644B2Jul 3, 2018

Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof

HOFFMANN LA ROCHE9 citations84
US7655651B2Feb 2, 2010

Amide derivatives of 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents

HOFFMANN LA ROCHE9 citations82
US7494993B2Feb 24, 2009

Amide derivatives of 7-amino-3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents

HOFFMANN LA ROCHE8 citations82
US10364292B2Jul 30, 2019

Monovalent blood brain barrier shuttle modules

HOFFMANN LA ROCHE10 citations81
US11787868B2Oct 17, 2023

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE1 citations72
US7226923B2Jun 5, 2007

Phthalazinone derivatives

HOFFMANN LA ROCHE8 citations70
US12358997B1Jul 15, 2025

Bispecific anti-human A-beta/anti-human transferrin receptor antibodies

HOFFMANN LA ROCHE0 citations62
US12030952B2Jul 9, 2024

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE1 citations62
US12522637B2Jan 13, 2026

Complement factor based affinity chromatography

HOFFMANN LA ROCHE0 citations61
US11440942B2Sep 13, 2022

Complement factor based affinity chromatography

HOFFMANN LA ROCHE0 citations61
US11945839B2Apr 2, 2024

Depletion of light chain mispaired antibody variants by hydrophobic interaction chromatography

HOFFMANN LA ROCHE1 citations57
US11780919B2Oct 10, 2023

Bispecific antigen binding molecules targeting OX40 and FAP

HOFFMANN LA ROCHE1 citations56
US10093714B1Oct 9, 2018

Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof

HOFFMANN LA ROCHE1 citations52
US11814409B2Nov 14, 2023

Fc-receptor based affinity chromatography

HOFFMANN LA ROCHE0 citations50
US7285569B2Oct 23, 2007

Tricycles, their manufacture and use as pharmaceutical agents

HOFFMANN LA ROCHE0 citations49
US7393936B2Jul 1, 2008

Method for the recombinant production and purification of protein kinases

HOFFMANN LA ROCHE0 citations40

CURIS INC

3 patents